Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 4
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients.
Reipert BM, Hofbauer CJ, Gangadharan B, Berg V, Donnachie E, Meeks S, Mancuso ME, Bowen J, Brown DL. Reipert BM, et al. J Clin Med. 2023 Mar 6;12(5):2080. doi: 10.3390/jcm12052080. J Clin Med. 2023. PMID: 36902866 Free PMC article.
The aim of the study described in this manuscript was the development of training and qualification test procedures to enable local operators in different European and US clinical Hemophilia Treatment Centers (HTC) to produce reliable and valid data for antigen-induced gen …
The aim of the study described in this manuscript was the development of training and qualification test procedures to enable local operator …
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
Pabinger I, Mamonov V, Windyga J, Engl W, Doralt J, Tangada S, Spotts G, Ewenstein B. Pabinger I, et al. Haemophilia. 2021 May;27(3):e331-e339. doi: 10.1111/hae.14219. Epub 2021 Mar 27. Haemophilia. 2021. PMID: 33772963 Free PMC article. Clinical Trial.
AIM: To compare the perioperative haemostatic efficacy and safety of antihaemophilic factor (recombinant) (ADVATE() ; Baxalta US Inc., a Takeda company, Lexington, MA, USA) CI or BI administration. ...
AIM: To compare the perioperative haemostatic efficacy and safety of antihaemophilic factor (recombinant) (ADVATE() ; Baxalta US I …
A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen.
Kennedy M, O'Gorman P, Monaghan A, Lavin M, O'Mahony B, O'Connell NM, O' Donnell JS, Turecek PL, Gormley J; Irish Personalised Approach to the Treatment of Haemophilia (iPATH) study group. Kennedy M, et al. Haemophilia. 2021 Jul;27(4):544-562. doi: 10.1111/hae.14282. Epub 2021 Mar 10. Haemophilia. 2021. PMID: 33751742 Free PMC article. Review.